Max Planck Innovation concludes around 80 license contracts a year, divided more or less equally between domestic and foreign companies. The type and scope of the licenses vary, as does the form of agreed payments. They extend from one-off payments (upfront payment) and pro-rata sales revenues (license fees) through to milestone payments extending beyond like the development of medicines. At present, several such potential revenues drivers are in development at our industrial partners.

Click to zoom:

Our success – since we launched our professional support for company founders in 1990 – is clearly visible:

• 146 companies founded
• 107 spin-offs actively accompanied by Max Planck Innovation
• 61 venture capital instances (13 of these with corporate financing)
• 44 MPG participations, 16 of these exits, 4 liquidations and 9 amortizations, thus 15 active participations
• 7 listed companies 2
• 6 company sales or fusions (M&A deals), some of these in the two-digit million range
• approx. 5,600 new workplaces, all in industries with a bright future
• 18 participations or economic revenue shares of Max Planck Innovation, one insolvent, two in liquidation and one sold
• 77% of the companies founded since 1990 are still in existence

Click to zoom:

Extract:

Extract: